» Authors » Yasuhiro Shimojima

Yasuhiro Shimojima

Explore the profile of Yasuhiro Shimojima including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 138
Citations 836
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ichikawa T, Kishida D, Shimojima Y, Yajima N, Oguro N, Yoshimi R, et al.
J Rheumatol . 2025 Mar; PMID: 40089302
Objective: The growing use of social networking services (SNSs) has impacted how patients with systemic lupus erythematosus (SLE) access health information, potentially influencing their interaction with healthcare providers. This study...
2.
Kawamori K, Oguro N, Shimizu K, Kida T, Omura S, Nakagomi D, et al.
Mod Rheumatol . 2025 Jan; PMID: 39887020
Objectives: Cytomegalovirus (CMV) reactivation during immunosuppressive therapy poses a risk of severe infections. This study aimed to investigate the risk factors of CMV reactivation in patients with microscopic polyangiitis and...
3.
Ogita C, Noguchi K, Takeuchi J, Azuma N, Omura S, Nakagomi D, et al.
Immunol Med . 2025 Jan; 1-8. PMID: 39797708
Rituximab (RTX) has been reported to effectively maintain remission in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV). In this multicenter study involving 57 patients who achieved remission after 24 weeks, we evaluated...
4.
Nishioka R, Omura S, Nakagomi D, Abe Y, Kadoya M, Takizawa N, et al.
Mod Rheumatol . 2024 Dec; PMID: 39716472
Objective: To assess the prevalence and outcomes among regimens of glucocorticoid tapering for microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) in real-world practice. Methods: We retrospectively examined the Japan...
5.
Tanomogi N, Shimojima Y, Ichikawa T, Kishida D, Sekijima Y
Int J Rheum Dis . 2024 Dec; 27(12):e70019. PMID: 39690511
No abstract available.
6.
Onishi T, Sada K, Hayashi K, Miyawaki Y, Yoshimi R, Shimojima Y, et al.
Arthritis Res Ther . 2024 Nov; 26(1):198. PMID: 39533345
Background: Pneumocystis jirovecii pneumonia (PCP) is an opportunistic infection in patients undergoing immunosuppressive therapy, such as glucocorticoid (GC) medication, for systemic autoimmune diseases like systemic lupus erythematosus (SLE). Despite the...
7.
Katayama Y, Miyawaki Y, Shidahara K, Nawachi S, Asano Y, Katsuyama E, et al.
Arthritis Res Ther . 2024 Nov; 26(1):195. PMID: 39529181
Background: Patient trust plays a central role in the patient-physician relationship. This study aimed to determine whether the number of outpatient visits with a covering rheumatologist is associated with patient...
8.
Sakurai N, Yoshimi R, Yajima N, Hidekawa C, Kunishita Y, Kishimoto D, et al.
Lupus . 2024 Sep; 33(12):1306-1316. PMID: 39226537
Objective: Late-onset systemic lupus erythematosus (LoSLE) is known to possess characteristics different from those of early-onset SLE (EoSLE), thereby making their diagnosis difficult. This study aimed to assess the characteristic...
9.
Shimojima Y, Nomura S, Ushiyama S, Ichikawa T, Takamatsu R, Kishida D, et al.
Autoimmun Rev . 2024 Aug; 23(7-8):103602. PMID: 39153646
Skeletal muscle involvement is common in patients with small- and medium-sized vasculitis, particularly polyarteritis nodosa (PAN) and antineutrophil cytoplasmic antibody-associated vasculitis (AAV). Despite being not included in the standard classification...
10.
Kidoguchi G, Yoshida Y, Watanabe H, Sugimoto T, Mokuda S, Kida T, et al.
Clin Rheumatol . 2024 Aug; 43(10):3195-3204. PMID: 39134873
We aimed to clarify the long-term safety and efficacy of rituximab (RTX) as a remission induction therapy following severe relapse in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). We...